Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) EBIT (2016 - 2025)

Historic EBIT for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to -$1.4 million.

  • Biomerica's EBIT fell 3826.79% to -$1.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$5.3 million, marking a year-over-year increase of 1059.6%. This contributed to the annual value of -$5.1 million for FY2025, which is 1931.84% up from last year.
  • Per Biomerica's latest filing, its EBIT stood at -$1.4 million for Q4 2025, which was down 3826.79% from -$1.1 million recorded in Q3 2025.
  • Over the past 5 years, Biomerica's EBIT peaked at -$107499.0 during Q1 2022, and registered a low of -$2.2 million during Q1 2021.
  • For the 5-year period, Biomerica's EBIT averaged around -$1.5 million, with its median value being -$1.6 million (2021).
  • As far as peak fluctuations go, Biomerica's EBIT surged by 9503.55% in 2022, and later crashed by 143582.82% in 2023.
  • Biomerica's EBIT (Quarter) stood at -$1.1 million in 2021, then crashed by 47.46% to -$1.7 million in 2022, then grew by 3.48% to -$1.6 million in 2023, then surged by 38.25% to -$993000.0 in 2024, then plummeted by 38.27% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q4 2025, -$1.1 million for Q3 2025, and -$1.6 million during Q2 2025.